Literature DB >> 6214360

Analysis of the pressor dose response.

D J Sumner, H L Elliott, J L Reid.   

Abstract

(1) When incremental infusions of drugs that increase blood pressure are given to human subjects to assess "pressor responsiveness," only the lower part of the sigmoid dose-response curve can be obtained. (2) Fitting a quadratic function does not involve discarding data points, which is usually the case with a linear fit, and it provides a more satisfactory fit to the lower part of a sigmoid dose-response curve. (3) In the presence of a competitive antagonist, a pressor dose-response curve will be shifted to the right. In this situation the dose-response curves obtained before and after treatment with antagonist should be fitted simultaneously to a quadratic model in which the parallel shift is one of the parameters. (4) The use of quadratic fitting is illustrated by reference to clinical experiments to obtain the following three curves for drugs that modify peripheral alpha adrenoceptors: norepinephrine pressor response curves after placebo and doxazosin, an alpha 1 antagonist; norepinephrine pressor response curves after placebo, labetalol, and medroxalol (drugs with combined alpha 1 and beta blocking properties); and phenylephrine pressor response curves before and after prazosin. (5) Fitting a quadratic function is the appropriate initial step in the analysis of pressor dose-response curves in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214360     DOI: 10.1038/clpt.1982.188

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

1.  Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.

Authors:  R F Schäfers; B Fokuhl; A Wasmuth; H Schumacher; K Taguchi; C de Mey; T Philipp; M C Michel
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

2.  A clinical pharmacological assessment of doxazosin and enalapril in combination.

Authors:  A D Bainbridge; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

3.  A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.

Authors:  S Ueda; P A Meredith; C A Howie; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

4.  Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.

Authors:  R F Schafers; H L Elliott; P A Meredith; S H Miller; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 5.  Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors?

Authors:  C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

6.  Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.

Authors:  J Vincent; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

7.  A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man.

Authors:  D J Sumner; H L Elliott; J Vincent; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

8.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

9.  Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.

Authors:  H L Elliott; K McLean; P A Meredith; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

10.  Beta adrenoreceptor subtype cross regulation in the human heart.

Authors:  J A Hall; A Ferro; J E Dickerson; M J Brown
Journal:  Br Heart J       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.